Common use of Business Recitals Clause in Contracts

Business Recitals. Closing 5.1 Closing Date 5.1 Closing Date Cash Payment 4.1(b)(i) Contingent Beds 4.3 Contingent Payment 4.3 Contingent Payment Determination Date 4.3 Contract(s) Requiring Consent 6.12(b) Disclosure Schedule Preamble Article VI Dispute Notice 4.2(a) Employment Agreements 5.4(n) Environmental Law 6.23(b) ERISA 6.26(a) ERISA Affiliate 6.26(b) Excluded Assets 2.2 Facilities Recitals Final Closing Date Statement 4.2(a) Financial Statements 6.8(a) FIRPTA Certificates 5.2(a)(viii) Four Month Anniversary 4.1(b)(ii) GAAP 4.2(a) Hazardous Substance 6.23(c) Healthcare Laws 6.21(a) Holdback Payment 4.1(b)(ii) Income Statement 2.1(a) Indemnified Parties 10.4(a) Indemnifying Parties 10.4(a) Interim Financial Statements 6.8(a) Inventory 6.16 IT Systems 6.29(b) Term Section Losses 10.2 Motor Vehicles 2.1(l) Net Asset Value 4.2(a) Non-Competition Agreements 5.4(o) Owned Rights 6.28(a) Parent Preamble Payoff Amount 8.20 Personnel 6.18 Pharmacy Letter 5.2(a)(iv) Power of Attorney 5.2(a)(iii) Preliminary Closing Date Statement 4.2(a) Proceedings 6.6 Proprietary Rights 6.28(a) Purchase Price 4.1(b) Purchase Price Adjustment 4.2(a) Purchaser Preamble Purchaser Indemnified Parties 10.2 Release 6.23(d) Required Third Party Consents 5.4(e) Retained Liabilities 3.2 Reviewing Accountants 4.2(a) Seller Preamble Seller’s Rights 6.28(a) Tax(es) 6.27(i)(i) Tax Return 6.27(i)(ii) Trademark Assignment Agreement 5.2(a)(x) Trade Names 8.18 Trade Secrets 6.28(a) Transferred Assets 2.1 Transferred Employee 8.14 4 EXHIBIT B FORM OF BXXX OF SALE EXHIBIT C FORM OF ASSIGNMENT AND ASSUMPTION AGREEMENT EXHIBIT D FORM OF POWER OF ATTORNEY EXHIBIT E FORM OF PHARMACY LETTER EXHIBIT F FORM OF TRADEMARK ASSIGNMENT AGREEMENT SCHEDULE 1 CONTINGENT FACILITIES MXXXX CARE CASCADE PARK COMMUNITIES MESSANGER HOUSE ENCORE COMMUNITIES ASSISTED LIVING REHABCO INC — LYNNWOOD PROGRAM MAKSU INC — PROGRAMS 2 & 3 PARK WEST CARE CENTER

Business Recitals. Buyer Preamble Buyer Indemnitee Section 6.01 Buyer’s Common Stock Section 1.04 Closing 5.1 Section 2.01 Closing Date 5.1 Closing Date Cash Payment 4.1(b)(iSection 2.01 CM Section 1.03 CM License Section 1.03 CM’s Transaction Shares Section 1.04 Confidentiality Agreement Section 5.01 Contracts Section 1.02(b) Contingent Beds 4.3 Contingent Payment 4.3 Contingent Payment Determination Date 4.3 Contract(s) Requiring Consent 6.12(bControl Section 1.03 Direct Claim Section 6.03(b) Disclosure Schedule Preamble Article VI Dispute Notice 4.2(aSchedules Section 1.01(d) Employment Agreements 5.4(nEncumbrance Section 3.07 Term Section Escrow Agent Section 2.02(b) Environmental Law 6.23(bEscrow Agreement Section 2.02(b) ERISA 6.26(a) ERISA Affiliate 6.26(bEscrow Shares Section 2.02(b) Excluded Assets 2.2 Facilities Recitals Final Closing Date Statement 4.2(a) Section 1.02 Financial Statements 6.8(aSection 3.04 Governmental Authority Section 1.01(h) FIRPTA Certificates 5.2(a)(viii) Four Month Anniversary 4.1(b)(ii) GAAP 4.2(a) Hazardous Substance 6.23(c) Healthcare Laws 6.21(a) Holdback Payment 4.1(b)(ii) Income Statement 2.1(a) Governmental Order Section 3.03 Indemnified Parties 10.4(aParty Section 6.03(a) Indemnifying Parties 10.4(aParty Section 6.03(a) Interim Financial Statements 6.8(aIntellectual Property Agreements Section 3.09 Intellectual Property Assets Section 1.01(c) Intellectual Property Registrations Section 3.09 Inventory 6.16 IT Systems 6.29(bSection 1.01(b) Term Law Section 3.03 Liabilities Section 1.03 Losses 10.2 Motor Vehicles 2.1(lSection 6.01 Material Adverse Effect Section 3.03 Members Preamble Membership Interests Section 3.02 Nasdaq Section 2.02(b)(ii) Net Asset Value 4.2(aPermits Section 3.12(b) Non-Competition Agreements 5.4(o) Owned Rights 6.28(a) Parent Preamble Payoff Amount 8.20 Personnel 6.18 Pharmacy Letter 5.2(a)(iv) Power of Attorney 5.2(a)(iii) Preliminary Closing Date Statement 4.2(a) Proceedings 6.6 Proprietary Rights 6.28(a) Person Section 3.03 Purchased Assets Section 1.01 Purchase Price 4.1(b) Purchase Price Adjustment 4.2(a) Purchaser Preamble Purchaser Indemnified Parties 10.2 Release 6.23(d) Required Third Party Consents 5.4(e) Retained Liabilities 3.2 Reviewing Accountants 4.2(a) Section 1.04 Purchased Websites Section 5.06 Securities Act Section 1.06 Seller Preamble Seller’s Rights 6.28(aCM Liabilities Section 1.03 Execution Copy Term Section Selling Parties Preamble Selling Parties’ Authorized Agent Section 7.14 Seller Indemnitee Section 6.02 Tangible Personal Property Section 1.01(c) Tax(es) 6.27(i)(iTaxes Section 3.13(b) Tax Return 6.27(i)(iiReturns Section 1.05 Third Party Claim Section 6.03 Transaction Documents Section 2.02(a)(ii) Trademark Assignment Agreement 5.2(a)(x) Trade Names 8.18 Trade Secrets 6.28(a) Transferred Assets 2.1 Transferred Employee 8.14 4 EXHIBIT B FORM OF BXXX C XXXX OF SALE EXHIBIT C FORM AND ASSIGNMENT (see attached) Execution Copy XXXX OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENT EXHIBIT D FORM OF POWER OF ATTORNEY EXHIBIT E FORM OF PHARMACY LETTER EXHIBIT F FORM OF TRADEMARK ASSIGNMENT AGREEMENT SCHEDULE 1 CONTINGENT FACILITIES MXXXX CARE CASCADE PARK COMMUNITIES MESSANGER HOUSE ENCORE COMMUNITIES ASSISTED LIVING REHABCO INC — LYNNWOOD PROGRAM MAKSU INC — PROGRAMS 2 & 3 PARK WEST CARE CENTERJuly 1, 2020 Pursuant to that certain Asset Purchase Agreement (the “Purchase Agreement”), dated as of even date herewith, by and among Quantitative Medicine LLC, a Delaware limited liability company (“Seller”), the members of Seller (collectively, the “Members” and jointly and severally with Seller, the “Selling Parties”), and Predictive Oncology, Inc., a Delaware corporation (“Buyer”), for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged:

Business Recitals. Buyer Preamble Buyer Group 9.7 Cases Recitals Cash and Cash Equivalents 2.2(a) Cash Purchase Price 3.2(a) Claim Over 9.7 Claims 2.1(f) Closing 5.1 3.1(a) Closing Date 5.1 Closing Date Cash Payment 4.1(b)(i3.1(a) Contingent Beds 4.3 Contingent Payment 4.3 Contingent Payment Determination Date 4.3 Contract(sCommittee 6.5(c) Requiring Consent 6.12(bCompeting Transaction 6.17(a) Deposit Adjustment Amount 3.5(b) Designated Change 6.14(b) Disclosure Statement 6.3(a) Early Closing Election 8.3(c) Early Funding Date 3.1 Early Funding Date Working Capital 3.4(b) Exxxxxx Money Deposit 3.3 Employee Benefit Plans 4.23(a) Term Section Employee Schedule Preamble Article VI Dispute Notice 4.2(a6.8(a) Employment Agreements 5.4(n) Environmental Law 6.23(b) ERISA 6.26(aEquipment 2.1(b) ERISA Affiliate 6.26(b4.23(a) Estimated Early Funding Date Working Capital 3.4(a) Exchange Act 4.6(c) Excluded Assets 2.2 Facilities Recitals Excluded Liabilities 2.4 Exclusivity Period 6.3(d)(iii) Final Closing Date Statement 4.2(aPerformance Adjustment Amount 3.6(b) Final Working Capital 3.4(i) Financial Statements 6.8(a4.6(a) FIRPTA Certificates 5.2(a)(viiiForm 10-Q 5.8 good faith 6.3(b) Four Month Anniversary 4.1(b)(iiGuidance 6.28(a) GAAP 4.2(aILECs 3.5(a) Hazardous Substance 6.23(cILEC Cure Amounts 3.5(a) Healthcare Laws 6.21(aILEC Set Off Amounts 3.5(a) Holdback Payment 4.1(b)(iiInitial Working Capital Adjustment 3.4(f) Income Statement Intellectual Property 2.1(i) Liquidated Damages 8.2 Losses 9.7 Master Services Agreement 6.26 Multiemployer Plan 4.23(d) multiple employer plan 4.23(a) No Action Relief 6.28(a) Non-Compete Covenants 6.1(j) Non-ILEC Cure Adjustment 3.5(c) Non-ILEC Cure Amounts 3.5(c) Non-ILEC Set Off Amounts 3.5(c) Non-Recourse Person 9.7 Non-Transferred Assets 2.5 Operating Agreement 7.2(g) Operating Subsidiaries 2.1(s) Owned Real Property 2.2(l) Performance Adjustment Amount 3.6(a) Personal Property Leases 2.1(c) Purchase Price 3.2 Purchase Price Cash Escrow 3.2(b) Purchase Price Escrow Agent 3.2(b) Purchase Price Escrow Agreement 3.2(b) Purchase Price Escrow Amount 3.2(b) Purchase Price Stock Escrow 3.2(b) Real Property Leases 2.1(a) Indemnified Parties 10.4(a) Indemnifying Parties 10.4(a) Interim Financial Statements 6.8(a) Inventory 6.16 IT Systems 6.29(b) Term Section Losses 10.2 Motor Vehicles 2.1(lRequired Interconnection Agreements 2.5 SEC 4.6(c) Securities Act 6.28 Seller Marks 6.24 Sellers Preamble Sellers’ Intentional Breach 8.2 Senior Credit Agreement 4.12 Shared Hosting Business 6.1 Shareholder Approval 6.29 Third Person 9.7 Total Gross End User Revenue 3.6(a) Total Retail Net Asset Value 4.2(a) Non-Competition Agreements 5.4(o) Owned Rights 6.28(a) Parent Preamble Payoff Amount 8.20 Personnel 6.18 Pharmacy Letter 5.2(a)(iv) Power of Attorney 5.2(a)(iii) Preliminary Closing Date Statement 4.2(a) Proceedings 6.6 Proprietary Rights 6.28(a) Purchase Price 4.1(b) Purchase Price Adjustment 4.2(a) Purchaser Preamble Purchaser Indemnified Parties 10.2 Release 6.23(d) Required Third Party Consents 5.4(e) Retained Liabilities 3.2 Reviewing Accountants 4.2(a) Seller Preamble Seller’s Rights 6.28(a) Tax(es) 6.27(i)(i) Tax Return 6.27(i)(ii) Trademark Assignment Agreement 5.2(a)(x) Trade Names 8.18 Trade Secrets 6.28(aEnding Lines 3.6(a) Transferred Assets 2.1 Transferred Employee 8.14 4 EXHIBIT B FORM OF BXXX OF SALE EXHIBIT C FORM OF ASSIGNMENT AND ASSUMPTION AGREEMENT EXHIBIT D FORM OF POWER OF ATTORNEY EXHIBIT E FORM OF PHARMACY LETTER EXHIBIT F FORM OF TRADEMARK ASSIGNMENT AGREEMENT SCHEDULE 1 CONTINGENT FACILITIES MXXXX CARE CASCADE PARK COMMUNITIES MESSANGER HOUSE ENCORE COMMUNITIES ASSISTED LIVING REHABCO INC — LYNNWOOD PROGRAM MAKSU INC — PROGRAMS 2 & 3 PARK WEST CARE CENTEREmployees 6.8(b) Transition Plan 6.2(a) Transition Services Agreement 7.3(d) Voting Agreement Recitals XO Common Stock 3.2(a)

Business Recitals. Cap Section 9.03(a) Closing 5.1 Section 2.03 Closing Date 5.1 Section 2.03 CMS Section 4.08(a) Company Change of Control Event Section 2.09(e)(iv) Company Units Recitals Continuing Employees Section 6.08(a) CPR Section 11.13(b) CPR Rules Section 11.13(b) Defense Notice Section 9.05 Determination Date Section 2.08(b) Dispute Section 11.13(a) Dispute Notice Section 11.13(b) Disputing Party Section 11.13(a) DOJ Section 4.08(a) Earn-Out Consideration Section 2.09(b) Earn-Out Deliveries Section 2.09(d) Earn-Out Financial Statements Section 2.09(d) Earn-Out Year Section 2.09(c) Environmental Laws Section 4.19(a) Escrow Agent Section 9.06(c) Escrow Fund Section 9.06(c) Escrow Termination Date Section 9.06(d) Estimated Closing Date Cash Payment 4.1(b)(i) Contingent Beds 4.3 Contingent Payment 4.3 Contingent Payment Determination Indebtedness Amount Section 2.02 Estimated Closing Date 4.3 Contract(s) Requiring Consent 6.12(b) Disclosure Schedule Preamble Article VI Dispute Notice 4.2(a) Employment Agreements 5.4(n) Environmental Law 6.23(b) ERISA 6.26(a) ERISA Affiliate 6.26(bWorking Capital Section 2.02 Excluded Assets Section 2.01(b) Excluded Assets 2.2 Facilities Recitals Final Closing Date Statement 4.2(aLiabilities Section 2.01(b) Excluded Matters Section 9.06(b) Excluded Taxes Section 7.01 FDA Section 4.08(a) Financial Statements 6.8(aSection 4.06(a) FIRPTA Certificates 5.2(a)(viiiXxxx Xxxxxxx FTC Section 6.05(a) Four Month Anniversary 4.1(b)(iiFundamental Representations Section 9.01 Gross Profit Statement Section 2.09(d) GAAP 4.2(aGross Profit Target Section 2.09(b) Hazardous Substance 6.23(c) Healthcare Laws 6.21(a) Holdback Payment 4.1(b)(ii) Income Statement 2.1(a) HIPAA Section 4.09 HITECH Section 4.09 Indemnification Receivable Section 6.13 Indemnified Parties 10.4(a) Indemnifying Parties 10.4(aEvent Section 9.07 Indemnity Period Section 9.01 Insurance Policies Section 4.16 Intended Tax Treatment Section 2.10(a) Interim Financial Statements 6.8(aBalance Sheet Section 4.06(a) Inventory 6.16 IT Systems 6.29(bLosses Section 9.02 Manage Section 4.19(d) Material Contracts Section 4.15 Medfusion 401(k) Plans Section 6.08(e) Medtown North Georgia Section 1.01 Medtown South Section 1.01 Xxxxxxxx Section 6.09 Negotiation Period Section 11.13(a) New Benefit Plans Section 6.08(a) OIG Section 4.08(a) Party(ies) First Paragraph of Agreement Payee Audit Section 2.09(d) PDF Section 11.02 Personal Guarantee Section 4.15(a)(vi) Professional Authorizations Section 4.10 Purchased Assets Section 2.01(b) Purchaser Claims Section 9.03(a) Purchaser Indemnified Party(ies) Section 9.02 Releasee(s) Section 9.09 Restricted Period Section 6.11(c) Retail Pharmacy Section 6.11(c) Selling Party Indemnified Party(ies) Section 9.04(a) Selling Party Representative Section 9.08(a) Selling Party Representative Account Section 9.08(d) Selling Party Representative Account Fund Section 9.08(d) Selling Party Representative Account Release Date Section 9.08(d) Significant Holders Section 4.08(a) Significant Payors Section 4.21 Tax Consideration Section 2.10(b) Term Section Losses 10.2 Motor Vehicles 2.1(lThreshold Section 9.03(a) Net Asset Value 4.2(a) Non-Competition Agreements 5.4(o) Owned Rights 6.28(a) Parent Preamble Payoff Amount 8.20 Personnel 6.18 Pharmacy Letter 5.2(a)(iv) Power of Attorney 5.2(a)(iii) Preliminary Closing Date Statement 4.2(a) Proceedings 6.6 Proprietary Rights 6.28(a) Purchase Price 4.1(b) Purchase Price Adjustment 4.2(a) Purchaser Preamble Purchaser Indemnified Parties 10.2 Release 6.23(d) Required Third Party Consents 5.4(e) Retained Liabilities 3.2 Reviewing Accountants 4.2(a) Seller Preamble Seller’s Rights 6.28(a) Tax(es) 6.27(i)(i) Tax Return 6.27(i)(ii) Trademark Assignment Agreement 5.2(a)(x) Trade Names 8.18 Trade Secrets 6.28(a) Transferred Assets 2.1 Transferred Employee 8.14 4 EXHIBIT B FORM OF BXXX OF SALE EXHIBIT C FORM OF ASSIGNMENT AND ASSUMPTION AGREEMENT EXHIBIT D FORM OF POWER OF ATTORNEY EXHIBIT E FORM OF PHARMACY LETTER EXHIBIT F FORM OF TRADEMARK ASSIGNMENT AGREEMENT SCHEDULE 1 CONTINGENT FACILITIES MXXXX CARE CASCADE PARK COMMUNITIES MESSANGER HOUSE ENCORE COMMUNITIES ASSISTED LIVING REHABCO INC — LYNNWOOD PROGRAM MAKSU INC — PROGRAMS 2 & 3 PARK WEST CARE CENTERTransfer Taxes Section 7.02 Unaudited Financial Statements Section 4.06(a)

Business Recitals. Claims Section 3.9(b) Closing 5.1 Section 2.1(a) Closing Balance Sheet Section 2.7(e) Closing Date 5.1 Section 2.8 Closing Date Cash Payment 4.1(b)(iSection 2.5(b) Contingent Beds 4.3 Contingent Payment 4.3 Contingent Payment Determination Date 4.3 Contract(sCOBRA Section 3.21 Code Section 2.9 Confidentiality Agreement Section 5.6 Continuing Employee Section 5.7(c) Requiring Consent 6.12(bCurrent Independent Contractor Section 3.20(b) Disclosure Schedule Preamble Article VI Dispute Notice 4.2(aCustomer Nevada EBITDA Section 2.6(b) Employment Agreements 5.4(n) Environmental Law 6.23(bEffective Time Section 2.8 Employee Transfer Section 5.7(a) ERISA 6.26(aSection 3.21 Estimated Base Purchase Price Section 2.7(b) ERISA Affiliate 6.26(bEstimated Closing Balance Sheet Section 2.7(b) Estimated Closing Net Working Capital Section 2.7(b) Estimated Closing Statement Section 2.7(b) Estimated Purchased Cash Amount Section 2.7(b) Excluded Assets 2.2 Facilities Recitals Section 2.1 Excluded Contracts Section 2.2(c) Existing Customer Section 2.6(b) Final Base Purchase Price Section 2.7(e) Final Closing Date Statement 4.2(aNet Working Capital Section 2.7(e) Final Closing Net Working Capital Adjustment Amount Section 2.7(e) Final Closing Payment Section 2.7(e) Final Purchased Cash Amount Section 2.7(e) Financial Statements 6.8(a) FIRPTA Certificates 5.2(a)(viii) Four Month Anniversary 4.1(b)(ii) Section 3.3 GAAP 4.2(a) Hazardous Substance 6.23(c) Healthcare Laws 6.21(a) Holdback Payment 4.1(b)(ii) Income Statement 2.1(aSection 3.3 Indemnified Party Section 11.3(a) Indemnified Party Section 11.3(a) Initial Net Working Capital Adjustment Amount Section 2.5(b) J&J Introductory Paragraph J&J 401(k) Plan Section 5.7(c) J&J Benefit Plans Section 5.7(b) J&J Indemnification Cap Section 11.1(a) J&J Indemnified Parties 10.4(aSection 11.1(a) Indemnifying J&J Indemnified Parties 10.4(aBasket Section 11.1(a) Interim Financial Statements 6.8(aLatest Balance Sheet Section 3.3 Leased Real Property Section 3.12(b) Inventory 6.16 IT Systems 6.29(bLiens Section 3.8 Losses Section 11.1(a) Term Lost Customer Section Losses 10.2 Motor Vehicles 2.1(l2.6(b) Net Asset Value 4.2(aLost Customer Adjustment Amount Section 2.6(b) Lost Customer Nevada EBITDA Amount Section 2.6(b) Mediator Section 2.7(i) New Customer Section 2.5(b) New Customer Run-Rate EBITDA Section 2.6(b) New Lease Section 7.3 Non-Competition Agreements 5.4(ocompetition Period Section 6.3(a)(i) Owned Rights 6.28(aOfferree Employee Section 5.7(b) Outside Date Section 10.1(f) Parent Preamble Payoff 401(k) Plan Section 5.7(f) Party Introductory Paragraph Pipeline Engagements Section 3.10(c) Pre-Closing Period Section 2.6(b) Price Adjustment Amount 8.20 Personnel 6.18 Pharmacy Letter 5.2(a)(ivSection 2.7(f) Power of Attorney 5.2(a)(iii) Preliminary Closing Date Statement 4.2(a) Proceedings 6.6 Proprietary Rights 6.28(aProhibited Code Section 3.9(d)(ix) Purchase Price 4.1(bSection 2.5(a) Restricted Persons Section 6.3(a)(i) Restrictive Covenant Agreements Section 7.2 Review Period Section 2.7(h) Seller Introductory Paragraph Seller Arrangement Section 3.20(d) Seller Indemnification Cap Section 11.2(d) Seller Indemnified Parties Section 11.2 Seller Indemnified Parties Basket Section 11.2(d) Seller Indemnitors Section 11.1(a) Software License Agreement Section 7.7 Specified Consent Section 2.2(d)(i) Survival Period Section 11.5 Target Net Working Capital Section 2.7 Target Purchase Price Adjustment 4.2(aSection 2.6(b) Purchaser Preamble Purchaser Indemnified Parties 10.2 Release 6.23(dTaverns Agreement Section 7.5 Territory Section 6.3(a)(i) Required Third Party Consents 5.4(e) Retained Liabilities 3.2 Reviewing Accountants 4.2(a) Seller Preamble Seller’s Rights 6.28(a) Tax(es) 6.27(i)(i) Tax Return 6.27(i)(ii) Trademark Assignment Transition Services Agreement 5.2(a)(x) Trade Names 8.18 Trade Secrets 6.28(a) Transferred Assets 2.1 Transferred Employee 8.14 4 EXHIBIT B FORM OF BXXX OF SALE EXHIBIT C FORM OF ASSIGNMENT AND ASSUMPTION AGREEMENT EXHIBIT D FORM OF POWER OF ATTORNEY EXHIBIT E FORM OF PHARMACY LETTER EXHIBIT F FORM OF TRADEMARK ASSIGNMENT AGREEMENT SCHEDULE 1 CONTINGENT FACILITIES MXXXX CARE CASCADE PARK COMMUNITIES MESSANGER HOUSE ENCORE COMMUNITIES ASSISTED LIVING REHABCO INC — LYNNWOOD PROGRAM MAKSU INC — PROGRAMS 2 & 3 PARK WEST CARE CENTERSection 7.6